Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Thompson

Showing results (211-220 of 484) with videos related to

Pageof 49
Sort By:
The Journal of Urology|December 18, 2007
Association of polymorphisms in TGFB1 and prostate cancer prognosisTimothy C Brand, Carlos Bermejo, Edith Canby-Hagino, et al.
Clinical Genitourinary Cancer|March 9, 2022
Hereditary Cancer Gene Variants in Hispanic Men With a Personal or Family History of Prostate CancerChethan Ramamurthy, Eric W Stutz, Martin Goros, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 22, 2011
Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention TrialAlan R Kristal, Cathee Till, Elizabeth A Platz, et al.
American Journal of Epidemiology|February 10, 2010
Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trialJeannette M Schenk, Alan R Kristal, Marian L Neuhouser, et al.
JAMA Oncology|March 31, 2017
Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone InductionThomas W Flaig, Melissa Plets, Maha H A Hussain, et al.
Translational Psychiatry|October 3, 2023
Effects of vortioxetine on hippocampal-related cognitive impairment induced in rats by androgen deprivation as a model of prostate cancer treatmentAlexandra M Vaiana, Yidong Chen, Jonathan Gelfond, et al.
Cancer|October 19, 2011
Selective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention TrialStephen B Williams, Simpa Salami, Meredith M Regan, et al.
Journal of the National Cancer Institute|March 14, 2018
Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention TrialJoseph M Unger, Dawn L Hershman, Cathee Till, et al.
The Journal of Urology|April 14, 2012
Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECTYair Lotan, Phyllis J Goodman, Ramy F Youssef, et al.
American Journal of Epidemiology|May 5, 2011
Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trialJeannette M Schenk, Alan R Kristal, Kathryn B Arnold, et al.
Pageof 49

Showing results (211-220 of 484) with videos related to

Sort By:
Pageof 49
The Journal of Urology|December 18, 2007
Association of polymorphisms in TGFB1 and prostate cancer prognosisTimothy C Brand, Carlos Bermejo, Edith Canby-Hagino, et al.
Clinical Genitourinary Cancer|March 9, 2022
Hereditary Cancer Gene Variants in Hispanic Men With a Personal or Family History of Prostate CancerChethan Ramamurthy, Eric W Stutz, Martin Goros, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 22, 2011
Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention TrialAlan R Kristal, Cathee Till, Elizabeth A Platz, et al.
American Journal of Epidemiology|February 10, 2010
Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trialJeannette M Schenk, Alan R Kristal, Marian L Neuhouser, et al.
JAMA Oncology|March 31, 2017
Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone InductionThomas W Flaig, Melissa Plets, Maha H A Hussain, et al.
Translational Psychiatry|October 3, 2023
Effects of vortioxetine on hippocampal-related cognitive impairment induced in rats by androgen deprivation as a model of prostate cancer treatmentAlexandra M Vaiana, Yidong Chen, Jonathan Gelfond, et al.
Cancer|October 19, 2011
Selective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention TrialStephen B Williams, Simpa Salami, Meredith M Regan, et al.
Journal of the National Cancer Institute|March 14, 2018
Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention TrialJoseph M Unger, Dawn L Hershman, Cathee Till, et al.
The Journal of Urology|April 14, 2012
Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECTYair Lotan, Phyllis J Goodman, Ramy F Youssef, et al.
American Journal of Epidemiology|May 5, 2011
Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trialJeannette M Schenk, Alan R Kristal, Kathryn B Arnold, et al.
Pageof 49